A new antigaging group has been formed to accelerate the development of scientific documented interventions that will promote longer, healthier, more productive and more rewarding lives for all members of humanity.
The Academy for Health and Lifespan Research will host forums to share research findings. They will lobby governments in the United States, Europe, and elsewhere to increase funding and create new paths to approve age-slowing therapies.
In addition to government regulators, the academy’s target audience will be physicians, health insurers who pay for new medicines, as well as the general public.
Sinclair has also co-founded a Boston holding company called Life Biosciences that’s launched seven biotechs developing treatments for age-related conditions like dementia and infertility.
Another founding member of the academy is Lenny Guarente, a Massachusetts Institute of Technology professor and chief scientist at Elysium Health, a startup working to identify naturally occurring compounds that will help people live longer.
Founding members, who have already begun talking to health ministers and drug regulators in several countries, will convene an organizational meeting in Paris this summer. By 2020, they hope to host scientific meetings where they can present research data and even sponsor what Sinclair calls a “Davos-style” conference of world leaders to lay out their vision of boosting economic productivity and reducing medical costs by extending healthy life.
Researchers from the Buck Institute and Stanford are also involved.
Judith Campisi has signed on. She is one of the pioneers with the treatment of senescent cells.